Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-005080

Options or other derivatives

  • Director acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smith Robin L Director 2016-04-21 Grant or award · 5% Secured Convertible Note due December 2017 +0 D
Smith Robin L Director 2016-04-21 Grant or award · Common Stock Warrant +800,000 2,000,000 D
Loading xslF345X03/s103077_form4.xml…